These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1344 related items for PubMed ID: 26139985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
    Wu SY, Lan SH, Liu HS.
    World J Gastroenterol; 2016 Jan 07; 22(1):176-87. PubMed ID: 26755869
    [Abstract] [Full Text] [Related]

  • 6. Complex interactions between microRNAs and hepatitis B/C viruses.
    Fan HX, Tang H.
    World J Gastroenterol; 2014 Oct 07; 20(37):13477-92. PubMed ID: 25309078
    [Abstract] [Full Text] [Related]

  • 7. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.
    Tu T, Budzinska MA, Shackel NA, Jilbert AR.
    Liver Int; 2015 Jul 07; 35(7):1786-800. PubMed ID: 25640596
    [Abstract] [Full Text] [Related]

  • 8. microRNAs and Hepatitis B.
    Naito Y, Tanaka Y, Ochiya T.
    Adv Exp Med Biol; 2015 Jul 07; 888():389-99. PubMed ID: 26663193
    [Abstract] [Full Text] [Related]

  • 9. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 10. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.
    Tan YL, Chen WN.
    World J Gastroenterol; 2014 May 28; 20(20):5973-86. PubMed ID: 24876720
    [Abstract] [Full Text] [Related]

  • 11. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y, Pu R, Han X, Zhao J, Li W, Yin J, Zhang Y, Shen Q, Xie J, Zhang Q, Jiang S, Li J, Zhang H, Wang H, Cao G.
    Liver Int; 2014 May 28; 34(5):728-36. PubMed ID: 24118778
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG.
    Oncol Rep; 2011 Nov 28; 26(5):1281-6. PubMed ID: 21725618
    [Abstract] [Full Text] [Related]

  • 14. The function of MicroRNA in hepatitis B virus-related liver diseases: from Dim to Bright.
    Yu K, Shi G, Li N.
    Ann Hepatol; 2015 Nov 28; 14(4):450-6. PubMed ID: 26019030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Moyo B, Nicholson SA, Arbuthnot PB.
    Virus Res; 2016 Jan 02; 212():103-13. PubMed ID: 26239319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
    Sukowati CH, El-Khobar KE, Ie SI, Anfuso B, Muljono DH, Tiribelli C.
    World J Gastroenterol; 2016 Jan 28; 22(4):1497-512. PubMed ID: 26819517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.
    Wang Y, Cao J, Zhang S, Sun L, Nan Y, Yao H, Fan J, Zhu LY, Yu L.
    Cell Death Dis; 2019 Oct 14; 10(10):783. PubMed ID: 31611549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.